CLINICAL_TRIALS
research
· 2026-03-10
Clinical Trial Update: A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia [Phase 1]
Summary
A Phase 1 clinical trial evaluating ADCLEC.syn1 in adults with acute myeloid leukemia is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: RECRUITING